Evaluating the cost-effectiveness of respiratory syncytial virus vaccination among risk-stratified older adults
{{output}}
Respiratory syncytial virus (RSV) disproportionately affects older adults with chronic conditions. RSV vaccines are effective but costly, and post-licensure studies suggest increased risk of Guillain-Barre syndrome (GBS). We evaluated cost-effectiveness and ri... ...
